Loading clinical trials...
Loading clinical trials...
This study is designed to examine L. plantarum PS128 can improve symptoms in early onset PD patients. L. plantarum PS128 is a psychobiotic that regulates the level of dopamine in specific brain regions. Patients with early onset PD will receive PS128 treatment for 12 weeks. Symptoms of PD will be clinically evaluated before and after the treatment, and the results will be compared.
Age
20 - 80 years
Sex
ALL
Healthy Volunteers
No
Professor Lu Neurological Clinic
Taoyuan, Guishan Dist., Taiwan
Start Date
October 27, 2020
Primary Completion Date
December 31, 2021
Completion Date
December 31, 2021
Last Updated
January 25, 2021
20
ESTIMATED participants
PS128
DIETARY_SUPPLEMENT
Lead Sponsor
Professor Lu Neurological Clinic
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions